<?xml version="1.0" encoding="UTF-8"?>
<p>As cases of COVID‐19, the disease caused by the novel coronavirus (SARS‐CoV‐2), continue to spread globally, public health experts have warned about the devastating impact this pandemic may have on society’s most vulnerable [
 <xref rid="jia225551-bib-0001" ref-type="ref">1</xref>]. Meanwhile, another public health crisis, the opioid epidemic, rages on throughout the United States [
 <xref rid="jia225551-bib-0002" ref-type="ref">2</xref>, 
 <xref rid="jia225551-bib-0003" ref-type="ref">3</xref>]. In other parts of the world, the use of opiates and opioids has remained relatively stable; however, in Eastern Europe, Russia and Central Asia opiate use has increased [
 <xref rid="jia225551-bib-0004" ref-type="ref">4</xref>]. In these regions, the prevalence of injection drug use is high, as is prevalence of HIV among people who inject drugs – over 40% in major Russian cities according to recent estimates [
 <xref rid="jia225551-bib-0005" ref-type="ref">5</xref>]. Worldwide nearly half a million people died as a result of drug misuse in 2015; 168,000 of those deaths were due to overdose [
 <xref rid="jia225551-bib-0006" ref-type="ref">6</xref>]. People living with HIV (PLWH) face higher risk of opioid misuse than HIV‐negative people, in part because PLWH are more likely to suffer chronic pain and receive opioid analgesic treatment for symptom relief [
 <xref rid="jia225551-bib-0007" ref-type="ref">7</xref>, 
 <xref rid="jia225551-bib-0008" ref-type="ref">8</xref>].
</p>
